𝔖 Bobbio Scriptorium

✦ LIBER ✦

OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease

✍ Scribed by Knop, S; Hebart, H; Gscheidle, H; Holler, E; Kolb, H-J; Niederwieser, D; Einsele, H

Book ID: 110014765
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 134 KB
Volume: 36
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1705132

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Filgrastim Treatment of Acute Myelogenou

Filgrastim Treatment of Acute Myelogenous Leukemia (M7) Relapse after Allogeneic Peripheral Stem Cell Transplantation Resulting in Both Graft-versus-Leukemia Effect with Cytogenetic Remission and Chronic Graft-versus-Host Disease Manifesting as Polyserositis and Subsequent Bronchiolitis Obliterans with Organizing Pneumonia

✍ L. Law; J. Tuscano; T. Wun; K. Ahlberg; C. Richman 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 97 KB

340: Response to Steroids as Primary The

340: Response to Steroids as Primary Therapy for Acute Graft-Versus-Host Disease (GVHD) in 280 Hematopoietic Stem Cell Transplant (HSCT) Recipients: Comparison of Unrelated Donor (URD) Bone Marrow (BM) and Umbilical Cord Blood (UCB)

✍ M.L. MacMillan; J.E. Wagner; M. Arora; T.E. DeFor; B.R. Blazar; D.J. Weisdorf 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB